Chrysin serves as a novel inhibitor of DGKα/FAK interaction to suppress the malignancy of esophageal squamous cell carcinoma (ESCC)

Jie Chen(Louisiana State University Health Sciences Center Shreveport), Qimin Zhan(Peking University Cancer Hospital), Di Zhao(Peking University), Yan Wang(Cangzhou Central Hospital), Lingyuan Zhang(Peking University), Weimin Zhang(Peking University), Jiawen Fan(Peking University), Jinting Li(Heilongjiang University of Chinese Medicine)
Acta Pharmaceutica Sinica B
July 22, 2020
Cited by 24


Related Papers